Alzheimer's disease: Potential pathogenesis and imaging findings

Abstract Alzheimer's disease (AD) is a common neurodegenerative disease. The histopathological changes in AD include amyloid β‐protein (Aβ) deposition, tau tangles, neuroinflammation, and neurodegeneration. Some of the pathological changes could be shown in vivo by positron emission tomography...

Full description

Bibliographic Details
Main Authors: Yan Zhang, Chenpeng Zhang, Jianjun Liu, Hongda Shao
Format: Article
Language:English
Published: Wiley 2023-10-01
Series:View
Subjects:
Online Access:https://doi.org/10.1002/VIW.20230025
_version_ 1827787578401619968
author Yan Zhang
Chenpeng Zhang
Jianjun Liu
Hongda Shao
author_facet Yan Zhang
Chenpeng Zhang
Jianjun Liu
Hongda Shao
author_sort Yan Zhang
collection DOAJ
description Abstract Alzheimer's disease (AD) is a common neurodegenerative disease. The histopathological changes in AD include amyloid β‐protein (Aβ) deposition, tau tangles, neuroinflammation, and neurodegeneration. Some of the pathological changes could be shown in vivo by positron emission tomography (PET) and magnetic resonance imaging (MRI) biomarkers, which play a key role in diagnosing AD. Fluorodeoxyglucose positron emission tomography (FDG‐PET) can reflect and predict dysfunction. Aβ‐PET is sensitive for the diagnosis of early AD but cannot distinguish the severity of AD. Tau‐PET can compensate for the deficiency of Aβ‐PET. Tau tangles are positively correlated with the severity of AD and associated with cognitive impairment. Probes targeting neuroinflammation in AD have been developed, but further study is needed to validate their effectiveness. Conventional MRI performs high tissue contrast that can show structural changes and has been routinely applied in clinical practice, such as in the evaluation of cerebral atrophy. Advanced MRI sequences (such as diffusion tensor imaging, arterial spin labeling, magnetic resonance spectroscopy, blood oxygenation level dependent, and quantitative susceptibility mapping) can provide additional information beyond structure that includes brain microstructure, blood perfusion, metabolite concentration, brain activity, connections and networks between brain regions, iron deposition, etc. Integrated PET and MRI may improve the diagnostic efficiency of AD.
first_indexed 2024-03-11T16:51:57Z
format Article
id doaj.art-f81f828aa430415ca8fa448598caada7
institution Directory Open Access Journal
issn 2688-3988
2688-268X
language English
last_indexed 2024-03-11T16:51:57Z
publishDate 2023-10-01
publisher Wiley
record_format Article
series View
spelling doaj.art-f81f828aa430415ca8fa448598caada72023-10-21T07:46:14ZengWileyView2688-39882688-268X2023-10-0145n/an/a10.1002/VIW.20230025Alzheimer's disease: Potential pathogenesis and imaging findingsYan Zhang0Chenpeng Zhang1Jianjun Liu2Hongda Shao3Department of Nuclear Medicine Ren Ji Hospital Shanghai Jiao Tong University School of Medicine Shanghai ChinaDepartment of Nuclear Medicine Ren Ji Hospital Shanghai Jiao Tong University School of Medicine Shanghai ChinaDepartment of Nuclear Medicine Ren Ji Hospital Shanghai Jiao Tong University School of Medicine Shanghai ChinaDepartment of Nuclear Medicine Ren Ji Hospital Shanghai Jiao Tong University School of Medicine Shanghai ChinaAbstract Alzheimer's disease (AD) is a common neurodegenerative disease. The histopathological changes in AD include amyloid β‐protein (Aβ) deposition, tau tangles, neuroinflammation, and neurodegeneration. Some of the pathological changes could be shown in vivo by positron emission tomography (PET) and magnetic resonance imaging (MRI) biomarkers, which play a key role in diagnosing AD. Fluorodeoxyglucose positron emission tomography (FDG‐PET) can reflect and predict dysfunction. Aβ‐PET is sensitive for the diagnosis of early AD but cannot distinguish the severity of AD. Tau‐PET can compensate for the deficiency of Aβ‐PET. Tau tangles are positively correlated with the severity of AD and associated with cognitive impairment. Probes targeting neuroinflammation in AD have been developed, but further study is needed to validate their effectiveness. Conventional MRI performs high tissue contrast that can show structural changes and has been routinely applied in clinical practice, such as in the evaluation of cerebral atrophy. Advanced MRI sequences (such as diffusion tensor imaging, arterial spin labeling, magnetic resonance spectroscopy, blood oxygenation level dependent, and quantitative susceptibility mapping) can provide additional information beyond structure that includes brain microstructure, blood perfusion, metabolite concentration, brain activity, connections and networks between brain regions, iron deposition, etc. Integrated PET and MRI may improve the diagnostic efficiency of AD.https://doi.org/10.1002/VIW.20230025Alzheimer's diseasemagnetic resonance imagingneuroimagingpositron emission computed tomography
spellingShingle Yan Zhang
Chenpeng Zhang
Jianjun Liu
Hongda Shao
Alzheimer's disease: Potential pathogenesis and imaging findings
View
Alzheimer's disease
magnetic resonance imaging
neuroimaging
positron emission computed tomography
title Alzheimer's disease: Potential pathogenesis and imaging findings
title_full Alzheimer's disease: Potential pathogenesis and imaging findings
title_fullStr Alzheimer's disease: Potential pathogenesis and imaging findings
title_full_unstemmed Alzheimer's disease: Potential pathogenesis and imaging findings
title_short Alzheimer's disease: Potential pathogenesis and imaging findings
title_sort alzheimer s disease potential pathogenesis and imaging findings
topic Alzheimer's disease
magnetic resonance imaging
neuroimaging
positron emission computed tomography
url https://doi.org/10.1002/VIW.20230025
work_keys_str_mv AT yanzhang alzheimersdiseasepotentialpathogenesisandimagingfindings
AT chenpengzhang alzheimersdiseasepotentialpathogenesisandimagingfindings
AT jianjunliu alzheimersdiseasepotentialpathogenesisandimagingfindings
AT hongdashao alzheimersdiseasepotentialpathogenesisandimagingfindings